Schober C - Search Results

1

Posttraumatic Ocular Hypotony Through Epithelial Downgrowth.

Heinzelmann J, Schober C, Huth A, Siebolts U, Viestenz A. Heinzelmann J, et al. Among authors: schober c. Klin Monbl Augenheilkd. 2022 Feb;239(2):191-195. doi: 10.1055/a-1332-1734. Epub 2021 Feb 4. Klin Monbl Augenheilkd. 2022. PMID: 33540462 English, German.

2

[Tyrosine kinase inhibitor-associated choroidopathy].

Schober C, Beyer JM, Fiorentzis M, Viestenz A. Schober C, et al. Ophthalmologe. 2020 Jun;117(6):566-570. doi: 10.1007/s00347-019-00964-y. Ophthalmologe. 2020. PMID: 31844929 German.

3

High frequency of secondary, but not primary ocular manifestations of inflammatory bowel disease in patients treated at a tertiary care center.

Walldorf J, Twarz M, Schober C, Michl P, Hammer T. Walldorf J, et al. Among authors: schober c. Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1502-1506. doi: 10.1097/MEG.0000000000001248. Eur J Gastroenterol Hepatol. 2018. PMID: 30148806

4

Impact of quality of life parameters and coping strategies on postchemotherapy nausea and vomiting.

Jordan K, Grothey A, Pelz T, Lautenschläger C, Franke U, Schöber C, Schmoll HJ. Jordan K, et al. Among authors: schober c. Eur J Cancer Care (Engl). 2010 Sep;19(5):603-9. doi: 10.1111/j.1365-2354.2009.01099.x. Epub 2009 Aug 31. Eur J Cancer Care (Engl). 2010. PMID: 19725867

5

[Diagnostic and therapeutic management of the superior vena cava syndrome].

Dempke W, Behrmann C, Schöber C, Büchele T, Grothey A, Schmoll HJ. Dempke W, et al. Among authors: schober c. Med Klin (Munich). 1999 Dec 15;94(12):681-4. doi: 10.1007/BF03044758. Med Klin (Munich). 1999. PMID: 10641510 Review. German.

6

A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.

Bokemeyer C, Franzke A, Hartmann JT, Schöber C, Arseniev L, Metzner B, Link H, Kanz L, Schmoll HJ. Bokemeyer C, et al. Among authors: schober c. Cancer. 1997 Oct 1;80(7):1221-7. Cancer. 1997. PMID: 9317171 Clinical Trial.

7

Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours.

Schöber C, Schmoll E, Schmoll HJ, Poliwoda H, Schuppert F, Stahl M, Bokemeyer C, Wilke H, Weiss J. Schöber C, et al. Eur J Cancer. 1992;28A(10):1664-6. doi: 10.1016/0959-8049(92)90064-9. Eur J Cancer. 1992. PMID: 1382494

8

Single-agent carboplatinum for advanced seminoma. A phase II study.

Schmoll HJ, Harstrick A, Bokemeyer C, Dieckmann KP, Clemm C, Berdel WE, Souchon R, Schöber C, Wilke H, Poliwoda H. Schmoll HJ, et al. Among authors: schober c. Cancer. 1993 Jul 1;72(1):237-43. doi: 10.1002/1097-0142(19930701)72:1<237::aid-cncr2820720142>3.0.co;2-l. Cancer. 1993. PMID: 8508413 Clinical Trial.

9

The role of schedule dependency of 5-fluorouracil/leucovorin combinations in advanced colorectal cancer.

Schöber C, Bokemeyer C, Stahl M, Wilke HJ, Schmoll HJ, Poliwoda H. Schöber C, et al. Semin Oncol. 1992 Apr;19(2 Suppl 3):131-5. Semin Oncol. 1992. PMID: 1557638

10

A 3-day schedule of 5-fluorouracil and folinic acid in metastatic progressive colorectal cancer and its impact in terms of palliation.

Schöber C, Köhne-Wömpner CH, Schmoll HJ, Stahl M, Wilke HJ, Poliwoda H. Schöber C, et al. Semin Oncol. 1992 Apr;19(2 Suppl 3):136-40. Semin Oncol. 1992. PMID: 1557639 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page